Loading clinical trials...
Loading clinical trials...
The purpose of this clinical research study is to learn if patients who receive vinflunine plus best supportive care live longer than patients who receive best supportive care alone. This study will a...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pierre Fabre Medicament
Collaborators
NCT05614739 · Urinary Bladder Neoplasms, Neoplasm Metastasis, and more
NCT06319820 · Non-Muscle Invasive Bladder Neoplasms
NCT07217171 · Bladder Cancer, Squamous Cell Carcinoma of the Lung, and more
NCT06851663 · Solid Tumor, Solid Carcinoma, and more
NCT06833073 · Urinary Bladder Neoplasms, Non-Muscle Invasive Bladder Neoplasms, and more
Local Institution
Calgary, Alberta
Local Institution
Edmonton, Alberta
Local Institution
Vancouver, British Columbia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions